David Shaw’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
David Shaw's KYMR Position: Q3 2026 in Review
David Shaw increased its Kymera Therapeutics (KYMR) stake by 39% in Q3 2026, buying an estimated $126K and bringing the position to 3,900 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #4329.
David Shaw first reported a position in KYMR in Q4 2020 and has held it in 11 quarters since. The position peaked at $8.91M in Q3 2024. 301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- David Shaw held 3,900 shares of Kymera Therapeutics worth $436K as of Q3 2026.
- David Shaw bought 1,100 Kymera Therapeutics shares in Q3 2026, an estimated $126K.
- Kymera Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4329 holding.
- David Shaw first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 11 quarters since.
- David Shaw's Kymera Therapeutics position peaked at $8.91M in Q3 2024.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.